Scientists discover new epigenetic cause of cblC that shifts rare disease paradigm
Researchers in France and Canada have discovered an epigenetic alteration…
Researchers in France and Canada have discovered an epigenetic alteration of a vitamin B12 gene – MMACHC – that has significant implications for our understanding of cblC and other rare diseases.